Search results
Author(s):
Jason M Tarkin
,
Juan Carlos Kaski
Added:
3 years ago
Stable angina pectoris is the most prevalent clinical manifestation of coronary heart disease. While the overall prognosis in patients with stable angina is good, with a low yearly event rate of ~1–2 %,1 for many, adequate symptom control can be difficult to achieve, leading to significantly impaired quality of life.
The traditional approach to the pharmacological management of stable angina, as…
View more
Author(s):
Gaetano Antonio Lanza
,
Hiroaki Shimokawa
Added:
10 months ago
Stable Angina Medical Therapy
Author(s):
Talla A Rousan
,
Udho Thadani
Added:
3 years ago
Article
Author(s):
Giacinta Guarini
,
Alda Huqi
,
Doralisa Morrone
,
et al
Added:
3 years ago
Although cardiovascular mortality has declined progressively in developed countries, ischaemic heart disease (IHD) and chronic stable angina cause a worse prognosis and poor quality of life and can dramatically increase healthcare costs.1–4 Traditionally, chronic stable angina has been interpreted as reversible episodes of myocardial ischaemia due to the presence of coronary artery disease…
View more
Author(s):
Abdalla Ibrahim
,
Mohamed Ali
,
Thomas J Kiernan
,
et al
Added:
3 years ago
Erectile dysfunction (ED) is generally defined as the persistent (at least 6 months) inability to achieve and maintain penile erection sufficient to allow satisfactory sexual performance.1 It is a common condition, and recent studies predict a higher prevalence of ED in the future.2 It is estimated that ED has affected more than 150 million men worldwide and this number will reach approximately…
View more
Author(s):
Aarti Thakkar
,
Anandita Agarwala
,
Erin D Michos
Added:
2 years ago
Author(s):
Ferenc Follath
Added:
3 years ago
Q: What are the new treatment options in acute decompensated heart failure?
A: The new treatment options are the two recently introduced drugs, the calcium sensitiser, levosimendan which has been introduced in many European countries, and a B-type natriuretic peptide (BNP) Analogon nesiritide, utilised primarily in the US. This BNP causes basal dilation and improves diuresis.
Q: How do these…
View more
Author(s):
Juan Carlos Kaski
,
Hiroaki Shimokawa
Added:
6 months ago
Author(s):
Philip A Poole-Wilson
Added:
3 years ago
Introduction
Coronary heart disease (CHD), due to atheromatous obstruction of coronary arteries, is the most common form of heart disease. The atheroma forms and accumulates in the wall of the coronary artery (coronary atherosclerosis) beginning at an early age. The disease is thought to be initiated by damage to the endothelium - the inner lining of the vessel wall - as a consequence of a…
View more